Purchase Order V5015D0043

The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm fixed-price delivery order contract to Takeda Pharmaceuticals America Inc., a subsidiary of Takeda Pharmaceutical Company LIMITED, for the supply of LANADELUMAB-FLYO (TAKHZYRO) 15OMG/ML INJ, SYRINGE, 2ML. This contract has a potential value of $110,671.20 and a completion date of June 6, 2024. The contract was issued against Takeda's Pharmaceuticals and Drugs General Services Administration (GSA) Schedule....

This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the supply of ONFI 2.5 mg/mL suspension in 120 mL bottles, with a potential value of $1,776.90 and a performance period through January 23, 2024. Amerisourcebergen Drug Corp, as a prime contractor, has a history of providing pharmaceutical and medical supply products to DLA Troop Support Medical facilities to...

The Department of Veterans Affairs (VA) awarded a firm fixed-price delivery order contract to Takeda Pharmaceuticals America Inc., a subsidiary of Takeda Pharmaceutical Company LIMITED, for the supply of the specialty pharmaceutical TAKHZYRO. The contract has a potential value of $36,890.40 and a completion date of April 24, 2024. Takeda Pharmaceuticals America Inc. is a prime contractor that provides a range of pharmaceutical products, including those to treat hemophilia, immune disorders,...

<p>SZY Holdings LLC has been awarded a firm fixed price purchase order by the Defense Logistics Agency Troop Support Medical for $1,618 to provide sugammadex sodium under contract number 8510310504. The place of performance is Brooklyn, NY and the period of performance extends through December 26, 2023. SZY Holdings LLC will deliver the pharmaceutical product to support defense health programs as a medical supplier. No set-aside provision was applied to this procurement.</p>

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZONISADE 100 MG/5 ML ORAL SUSP 150ML, a pharmaceutical product, with a ceiling value of $1,122.49 and a period of performance through March 28, 2025. The contract is a firm fixed-price delivery order, and there is no set-aside designation indicated. AmerisourceBergen holds...

This federal contract award was issued by the Department of Veterans Affairs (VA) to Otsuka America Pharmaceutical Inc., a for-profit pharmaceutical manufacturer and supplier. The contract, valued at $12,559.90, is for the delivery of the drug JYNARQUE (tolvaptan) in 90mg-30mg dosages. JYNARQUE is used to treat autosomal dominant polycystic kidney disease and hyponatremia. The contract is a Delivery Order under Otsuka's existing Federal Supply Schedule (FSS) contract with the VA, which has a...

This is a sole source delivery order awarded by the Department of Veterans Affairs (VA) to Otsuka America Pharmaceutical Inc., a for-profit pharmaceutical manufacturer. The contract, valued at $132,073.87, is for the supply of the specialty medication Jynarque (tolvaptan) to the VA's San Diego Pharmacy Service. Jynarque is used to treat autosomal dominant polycystic kidney disease and hyponatremia. The award is placed against Otsuka's $396 million Federal Supply Schedule (FSS) contract under the...

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply ONFI 2.5 MG/ML SUSPENSION 120ML, a prescription medication, to DLA facilities supporting the Department of Defense (DOD) worldwide. The contract has a ceiling value of $4,384.45 and is a Firm Fixed Price Delivery Order with a period of performance through June 21, 2024. This award is part of Amerisourcebergen's larger Indefinite Delivery...

This federal contract award was issued by the Department of Veterans Affairs (VA) to Otsuka America Pharmaceutical Inc., a for-profit pharmaceutical manufacturer and supplier. The contract, valued at $12,559.90, is a delivery order under Otsuka's existing Blanket Purchase Agreement (BPA) and Federal Supply Schedule (FSS) contract with the VA. The award is for the drug JYNARQUE 90MG/30MG, which is used to treat autosomal dominant polycystic kidney disease and hyponatremia. Otsuka has supplied...

This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical sourcing and distribution company. The contract is for the delivery of 4563956540 - ONFI 10 MG TABLET 100S, a pharmaceutical product, with a ceiling value of $3,336.16 and a period of performance through March 14, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with...